Aspira Women's Health

At Aspira Women’s Health’s annual general meeting, all four proposals put to a vote were approved. Six directors were elected for one year, executive compensation was approved on an advisory basis, and the stock incentive plan was increased by 5,000,000 to 9,532,818 shares. Shareholders also ratified BDO USA, P.C. as the independent auditor; the meeting was 62.40% represented. The stock has returned 310% over the past year, but the company still faces profitability challenges on $8.9 million in revenue for the last twelve months. » Plus sur de.investing.com

Aspira Women’s Health has entered into a subordinated, secured loan agreement with Agile Lending for USD 1.05 million, evidenced by a Subordinated Secured Promissory Note due August 26, 2026. If repaid on schedule, total interest costs will amount to USD 441,000; the loan is expressly subordinated to senior obligations. The company granted additional security interests in substantially all of its tangible assets and may use the proceeds for general corporate purposes; the agreement contains customary covenants, and lenders may enforce the security on covenant breaches. » Plus sur de.investing.com

Aspira Women’s Health has named Brian Hungerford chief financial officer and head of accounting, effective Tuesday; he succeeds Julie Carrillo. Hungerford will receive an annual salary of $300,000, a performance-based cash bonus of up to 35%, and stock options on 100,000 shares with staggered vesting beginning September 2, 2026. The contract includes termination and severance provisions for dismissal without cause and special provisions in the event of a change in control. The company also appointed Jane Pine Wood to the board of directors to strengthen the leadership team. » Plus sur de.investing.com